Collaborations & Alliances

AstraZeneca and Moderna in Oncology Collab

Moderna to lead preclinical development; AstraZeneca to lead clinical development

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

AstraZeneca, along with its global biologics research and development arm, MedImmune, and Moderna Therapeutics have formed a new collaboration to discover, co-develop and co-commercialize messenger RNA (mRNA) therapeutic candidates for the treatment of a range of cancers. The collaboration is in addition to the agreement announced by the companies in 2013 to develop mRNA Therapeutics for the treatment of cardiovascular, metabolic and renal diseases as well as selected targets in oncology. “We...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters